Additional Details
-
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
GSK Investigational SiteAnn Arbor MI. 48109 -
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
GSK Investigational SitePhiladelphia PA. 19140 -
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
GSK Investigational SiteTucson AZ. 85724 -
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
GSK Investigational SiteNew York NY. 10021 -
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
GSK Investigational SiteChicago IL. 60611 -
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
GSK Investigational SiteScottsdale AZ. 85258 -
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
GSK Investigational SitePotsdam NY. 13676 -
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
GSK Investigational SiteWashington DC. 20007 -
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
GSK Investigational SiteUpland CA. 91786 -
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
GSK Investigational SitePhoenix AZ. 85027 -
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
GSK Investigational SiteScottsdale AZ. 85259 -
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
GSK Investigational SiteAurora CO. 80033 -
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
GSK Investigational SiteHouston TX. 77030 -
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
GSK Investigational SiteNew Brunswick NJ. 08901 -
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
GSK Investigational SiteCincinnati OH. 45206 -
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
GSK Investigational SiteLos Angeles CA. 90095 -
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
GSK Investigational SiteBaltimore MD. 21224 -
Mycophenolate Mofetil in Systemic Sclerosis With Subclinical Interstitial Lung Disease
Institut Universitaire de Cardiologie et Pneumologie de QuébecQuebec City QC. -
Mycophenolate Mofetil in Systemic Sclerosis With Subclinical Interstitial Lung Disease
Jewish General Hospital - CIUSSS-COMTLMontreal QC. H3T 1E2 -
Mycophenolate Mofetil in Systemic Sclerosis With Subclinical Interstitial Lung Disease
Centre hospitalier de l'Université de Montréal (CHUM)Montreal QC. H2X 3E4